U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H18O4S2
Molecular Weight 242.356
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SULFONETHYLMETHANE

SMILES

CCC(C)(S(=O)(=O)CC)S(=O)(=O)CC

InChI

InChIKey=LKACJLUUJRMGFK-UHFFFAOYSA-N
InChI=1S/C8H18O4S2/c1-5-8(4,13(9,10)6-2)14(11,12)7-3/h5-7H2,1-4H3

HIDE SMILES / InChI

Approval Year

1895
3
Doses

Doses

DosePopulationAdverse events​
1 g 1 times / day single, oral
Studied dose
Dose: 1 g, 1 times / day
Route: oral
Route: single
Dose: 1 g, 1 times / day
Sources:
https://jamanetwork.com/journals/jama/article-abstract/452306
unhealthy, 39 years
Health Status: unhealthy
Age Group: 39 years
Sex: M
Sources:
https://jamanetwork.com/journals/jama/article-abstract/452306
Other AEs: Haematoporphyrinuria...
Other AEs:
Haematoporphyrinuria
Sources:
https://jamanetwork.com/journals/jama/article-abstract/452306
1 g 1 times / day multiple, oral
Studied dose
Dose: 1 g, 1 times / day
Route: oral
Route: multiple
Dose: 1 g, 1 times / day
Sources:
https://www.nejm.org/doi/pdf/10.1056/NEJM192409111911105
unhealthy, 44 years
Health Status: unhealthy
Age Group: 44 years
Sex: F
Sources:
https://www.nejm.org/doi/pdf/10.1056/NEJM192409111911105
Other AEs: Death...
Other AEs:
Death
Sources:
https://www.nejm.org/doi/pdf/10.1056/NEJM192409111911105
1 g 1 times / 2 days multiple, oral
Studied dose
Dose: 1 g, 1 times / 2 days
Route: oral
Route: multiple
Dose: 1 g, 1 times / 2 days
Sources:
https://zenodo.org/record/1789312/files/article.pdf?download=1
unhealthy, 50 years
Health Status: unhealthy
Age Group: 50 years
Sex: M
Sources:
https://zenodo.org/record/1789312/files/article.pdf?download=1
Other AEs: Neuritis NOS, Haematoporphyrinuria...
Other AEs:
Neuritis NOS
Haematoporphyrinuria
Sources:
https://zenodo.org/record/1789312/files/article.pdf?download=1
1.3 g 1 times / day single, oral
Studied dose
Dose: 1.3 g, 1 times / day
Route: oral
Route: single
Dose: 1.3 g, 1 times / day
Sources:
https://jamanetwork.com/journals/jama/article-abstract/463394
unhealthy, adult
Health Status: unhealthy
Age Group: adult
Sex: M
Sources:
https://jamanetwork.com/journals/jama/article-abstract/463394
Other AEs: Drowsiness...
Other AEs:
Drowsiness
Sources:
https://jamanetwork.com/journals/jama/article-abstract/463394
AEs

AEs

AESignificanceDosePopulation
Haematoporphyrinuria
1 g 1 times / day single, oral
Studied dose
Dose: 1 g, 1 times / day
Route: oral
Route: single
Dose: 1 g, 1 times / day
Sources:
https://jamanetwork.com/journals/jama/article-abstract/452306
unhealthy, 39 years
Health Status: unhealthy
Age Group: 39 years
Sex: M
Sources:
https://jamanetwork.com/journals/jama/article-abstract/452306
Death
1 g 1 times / day multiple, oral
Studied dose
Dose: 1 g, 1 times / day
Route: oral
Route: multiple
Dose: 1 g, 1 times / day
Sources:
https://www.nejm.org/doi/pdf/10.1056/NEJM192409111911105
unhealthy, 44 years
Health Status: unhealthy
Age Group: 44 years
Sex: F
Sources:
https://www.nejm.org/doi/pdf/10.1056/NEJM192409111911105
Haematoporphyrinuria
1 g 1 times / 2 days multiple, oral
Studied dose
Dose: 1 g, 1 times / 2 days
Route: oral
Route: multiple
Dose: 1 g, 1 times / 2 days
Sources:
https://zenodo.org/record/1789312/files/article.pdf?download=1
unhealthy, 50 years
Health Status: unhealthy
Age Group: 50 years
Sex: M
Sources:
https://zenodo.org/record/1789312/files/article.pdf?download=1
Neuritis NOS
1 g 1 times / 2 days multiple, oral
Studied dose
Dose: 1 g, 1 times / 2 days
Route: oral
Route: multiple
Dose: 1 g, 1 times / 2 days
Sources:
https://zenodo.org/record/1789312/files/article.pdf?download=1
unhealthy, 50 years
Health Status: unhealthy
Age Group: 50 years
Sex: M
Sources:
https://zenodo.org/record/1789312/files/article.pdf?download=1
Drowsiness
1.3 g 1 times / day single, oral
Studied dose
Dose: 1.3 g, 1 times / day
Route: oral
Route: single
Dose: 1.3 g, 1 times / day
Sources:
https://jamanetwork.com/journals/jama/article-abstract/463394
unhealthy, adult
Health Status: unhealthy
Age Group: adult
Sex: M
Sources:
https://jamanetwork.com/journals/jama/article-abstract/463394
Sourcing

Sourcing

Vendor/AggregatorIDURL
3B Scientific (Wuhan) Corp
3B3-022834
http://www.3bsc.com/index/pro_info.php?id=43910
ABI Chem
AC1L1MIU
ABI Chem
AC1Q2RZO
AHH Chemical co.,ltd
MT-30881
http://www.ahhchemical.com/product/MT-30881.html
Ambinter
Amb2221981
http://www.ambinter.com/reference/2221981
Chemieliva Pharmaceutical Co., Ltd
PBCM0818698
Debye Scientific
DS-007311
http://www.debyesci.com/cas_76-20-0.html
Enamine
BBV-40204292
LGC Standards
LGCFOR3149.00
https://www.lgcstandards.com/US/en/p/LGCFOR3149.00
LGC Standards
MM3149.00
https://www.lgcstandards.com/US/en/p/MM3149.00
mcule
MCULE-2164971606
https://mcule.com/MCULE-2164971606/
MP Biomedicals
201338
NovoSeek
6433
Scientific Exchange
POD_54/0791
Smolecule
S544193
http://www.smolecule.com/products/s544193
Tetrahedron
TS26899
THE BioTek
bt-282785
https://www.thebiotek.com/product/inhibitors/bt-282785
TimTec
ST45025623
http://www.echemstore.com/st45025623-1-1-bis-ethylsulfonyl-1-methylpropane.html
ZINC
ZINC000000002115
http://zinc15.docking.org/substances/ZINC000000002115
PubMed

PubMed

TitleDatePubMed
Costs of payment in Thai acute coronary syndrome patients.
2007-10
Estimating probabilities of peptide database identifications to LC-FTICR-MS observations.
2006-02-24
Study designs, duration, and choice of comparators including the use of placebo.
2002-12
Patents

Patents

JP1022898A
1
JP2000319357A
1
JP2002131536A
1
JP3094074B2
1
JP3630424B2
1
JPH07138347A
1
JPS06230735A
1
JPS63150224A
1
JPS63175327A
1
Name Type Language
SULFONETHYLMETHANE
MI  
Common Name English
METHYLSULFONAL
WHO-DD  
Preferred Name English
Methylsulfonal [WHO-DD]
Common Name English
NSC-3994
Code English
TRIONAL
Common Name English
SULFONETHYLMETHANE [MI]
Common Name English
METHYLSULPHONAL
Common Name English
DIETHYLSULFONMETHYLETHYLMETHANE
Common Name English
TRIONALON
Common Name English
2,2-BIS(ETHYLSULFONYL)BUTANE
Systematic Name English
SULPHONETHYLMETHANE
Common Name English
Classification Tree Code System Code
DEA NO. 2605
Created by admin on Mon Mar 31 18:15:48 GMT 2025 , Edited by admin on Mon Mar 31 18:15:48 GMT 2025
NCI_THESAURUS C29756
Created by admin on Mon Mar 31 18:15:48 GMT 2025 , Edited by admin on Mon Mar 31 18:15:48 GMT 2025
Code System Code Type Description
ECHA (EC/EINECS)
200-942-4
Created by admin on Mon Mar 31 18:15:48 GMT 2025 , Edited by admin on Mon Mar 31 18:15:48 GMT 2025
PRIMARY
CAS
76-20-0
Created by admin on Mon Mar 31 18:15:48 GMT 2025 , Edited by admin on Mon Mar 31 18:15:48 GMT 2025
PRIMARY
ChEMBL
CHEMBL1990189
Created by admin on Mon Mar 31 18:15:48 GMT 2025 , Edited by admin on Mon Mar 31 18:15:48 GMT 2025
PRIMARY
EVMPD
SUB14564MIG
Created by admin on Mon Mar 31 18:15:48 GMT 2025 , Edited by admin on Mon Mar 31 18:15:48 GMT 2025
PRIMARY
EPA CompTox
DTXSID7046411
Created by admin on Mon Mar 31 18:15:48 GMT 2025 , Edited by admin on Mon Mar 31 18:15:48 GMT 2025
PRIMARY
FDA UNII
217727W28W
Created by admin on Mon Mar 31 18:15:48 GMT 2025 , Edited by admin on Mon Mar 31 18:15:48 GMT 2025
PRIMARY
PUBCHEM
6433
Created by admin on Mon Mar 31 18:15:48 GMT 2025 , Edited by admin on Mon Mar 31 18:15:48 GMT 2025
PRIMARY
MERCK INDEX
m10358
Created by admin on Mon Mar 31 18:15:48 GMT 2025 , Edited by admin on Mon Mar 31 18:15:48 GMT 2025
PRIMARY Merck Index
NCI_THESAURUS
C74379
Created by admin on Mon Mar 31 18:15:48 GMT 2025 , Edited by admin on Mon Mar 31 18:15:48 GMT 2025
PRIMARY
WIKIPEDIA
TRIONAL
Created by admin on Mon Mar 31 18:15:48 GMT 2025 , Edited by admin on Mon Mar 31 18:15:48 GMT 2025
PRIMARY
SMS_ID
100000076220
Created by admin on Mon Mar 31 18:15:48 GMT 2025 , Edited by admin on Mon Mar 31 18:15:48 GMT 2025
PRIMARY
DRUG CENTRAL
3570
Created by admin on Mon Mar 31 18:15:48 GMT 2025 , Edited by admin on Mon Mar 31 18:15:48 GMT 2025
PRIMARY
NSC
3994
Created by admin on Mon Mar 31 18:15:48 GMT 2025 , Edited by admin on Mon Mar 31 18:15:48 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966